As a global leader in genomics, we continually strive to offer solutions that are not only innovative, but also accessible and always reliable. Illumina partnerships help advance genomics in numerous ways, from expanding access to next-generation sequencing (NGS) to pioneering new applications and technologies, providing funding for innovative startups, and more.
Some of our existing partnerships include:
Illumina and Roche partner to broaden the adoption of distributable next-generation sequencing-based testing in oncology.Read Press Release
Illumina forms multiple partnerships to develop precision oncology solutions.Read Press Release
Illumina and Loxo Oncology partner to develop next-generation sequencing-based pan-cancer companion diagnostics.Read Press Release
Discover more Illumina partnerships and collaborations designed to advance access to groundbreaking genomics solutions.
The partnership will expand capabilities for countries most impacted by tuberculosis to more effectively detect and combat multidrug-resistant TB.
The partnership focuses on commercializing oncology In Vitro Diagnostc (IVD) kits to support patient management and may expand to other clinical fields in the future.
The partnership brings together revolutionary Illumina NGS tools and a high-quality proprietary gut microbiome analysis platform from Microba to rapidly process large volumes of metagenomic data.
The partnership supports genomic analysis customers with innovative and secure, cloud-based data processing, management, and storage.
We strive to offer the best possible technologies and solutions to our customers. By integrating our technology with other best-in-class solutions, we aim to improve workflows, support groundbreaking research, and continue advancing genomics.Learn More
With mentorship, financial support, and access to sequencers and reagents, the Illumina Accelerator is helping genomics startups launch so we can unlock the power of the genome—together.Illumina for Startups
At AGBT 2024, Illumina presented several studies, highlighting improvements to NextSeq Systems and moreRead Article
Researchers at Okayama University in Japan use Illumina Connected Analytics with DRAGEN pipelines for analyzing whole-genome, exome, transcriptome, and metagenome dataRead Interview
Illumina leaders and other industry experts convene in London for the ninth annual Festival of Genomics & BiodataRead Article